Resources
49 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 11/1/2022 (updated 10/26/2023)
During the September 2022 Data Coordinator meetings, many of those who attended expressed interest in learning more about how to use their RCORP data to create a data visualization. Below, you’ll find the recording and slides from the session, Creating Data Visualizations with RCORP Data, held on October 25, 2022.
Posted 2/7/2023 (updated 10/26/2023)
This session was held for Implementation 4 grantees preparing for their first PIMS report, but the content is applicable to all RCORP cohorts who are interested in improving their data collection and reporting strategies.
Posted 7/12/2023 (updated 11/13/2023)
Below, you’ll find the slides and recording from the June 28th, 2023 session.
Posted 2/7/2023 (updated 2/20/2024)
This session was held for Implementation III grantees who are interested in learning more about how to access and utilize their recently released RCORP Data Dashboards. January Data Coordinator meeting content, which includes strategies for preventing common PIMS errors, is also covered during this session.
Posted 10/7/2019 (updated 3/25/2024)
It’s All About That Data (Panel Discussion) Webinar Reccording
Posted 10/7/2019 (updated 3/25/2024)
It’s All About That Data Webinar Presentation and Materials.
Posted 11/19/2019 (updated 3/25/2024)
The intersection of opioid abuse, particularly injection drug use (IDU), and HIV is well documented; in fact, IDU is the second most frequent route of HIV transmission. Injection drug use, either directly or via sexual contact with an IDU partner, accounts for one-third of the estimated AIDS cases since the beginning of the epidemic, and 18 percent of new infections in the United States.
Posted 2/9/2022 (updated 3/26/2024)
HRSA and JBS have developed guidance to assist your RCORP data collection and Performance Improvement Measurement System (PIMS) reporting efforts. These measures are pending OMB clearance and are subject to revision. This page contains the RCORP data collection resources for the Psychostimulant Support grantees only.
These documents will be updated as new guidance or data sources are identified. We encourage you to bookmark this page so you have the latest version available. Please send any measure-related questions to your HRSA Project Officer or email: rcorp-eval@jbsinternational.com.
Posted 2/9/2022 (updated 3/26/2024)
Summary of innovation abstracts that were presented at the National Academy of Medicine’s recent Stigma of Addiction Summit.
Posted 3/22/2022 (updated 3/27/2024)
The purpose of this document is to provide detailed guidelines of the Nurse Care Manager Model of Office Based Addiction Treatment program for management of substance use disorders, with particular emphasis on treatment of opioid use disorder with buprenorphine (alone and in combination with naloxone) and naltrexone (oral and extended-release injectable formulations).